|Articles|January 19, 2023
Leveraging the immunological diversity of the PentaMice® platform for COVID-19 antibody discovery
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
2
How Mitigation and Maintenance Protect Against Future Risk
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
5
